JPRN-UMIN000002290已完成1 期
Specific immunotherapy for multiple myeloma using vaccine complex consisting of idiotype protein and monosodium urate crystals (phase I study) - Phase I study of vaccine complex consisting of idiotype protein and monosodium urate crystals
ational Hospital Organization Awara Hospital0 个研究点目标入组 18 人开始时间: 2009年8月4日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 18
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Adolescents having major organ injury indicated by elevated level of serum creatinine, total bilirubin or ALT , or having symptomatic congestive heart failure Patients suffering from gout Patients with any of active autoimmune disease Patients with any of active infectious disease Women on (possible) pregnancy or lactation Adolescents judged inadequate by doctor in charge of the patient or the study
研究者
相似试验
已完成
不适用
The GMMG-HD5 trial: bortezomib-based induction prior to high dose therapy and autologous stem cell transplantation followed by lenalidomide-based consolidation and maintenance therapy in patients with multiple myelomaCancerMultiple myelomaISRCTN05745813Heidelberg University (Germany)504
进行中（未招募）
1 期
Monoclonal antibodies for treatment of bone marrow cancer. multiple myeloma.MedDRA version: 19.1Level: LLTClassification code 10028567Term: Myeloma, malignantSystem Organ Class: 100000004864Multiple MyelomaEUCTR2014-005189-31-DKDept Hematology SLB Vejle60
进行中（未招募）
1 期
Complex immunomodulatory therapy for patients with immune thrombocytopenia (T-MEM)Immune thrombocytopeniaMedDRA version: 23.0Level: PTClassification code: 10083842Term: Immune thrombocytopenia Class: 100000004851CTIS2023-505788-35-00Fakultni Nemocnice Hradec Kralove73
招募中
2 期
Romosozumab for Patients with Multiple Myeloma with Skeletal Events on Zoledronic Acid: A Pilot StudyCancer - MyelomaMultiple myelomaACTRN12624000027516St Vincent's Hospital, Sydney12
进行中（未招募）
1 期
Study of DTP3 in patients with relapsed or refractory multiple myeloma or diffuse large B-cell lymphomaCancerISRCTN13777452Imperial College London72